Business Description
Sagittarius Life Science Corp
ISIN : TW0003205001
Total Employee Number:
58Description
Sagittarius Life Science Corp is a Taiwan-based company engaged in the biotechnology and pharmaceutical sectors. The segment includes: Food and Others, with the majority of revenue from Food.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2087.13 | |||||
Equity-to-Asset | 0.97 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 79.48 | |||||
Beneish M-Score | -3.31 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -26.7 | |||||
3-Year EBITDA Growth Rate | 24.5 | |||||
3-Year EPS without NRI Growth Rate | 26.1 | |||||
3-Year FCF Growth Rate | 25.9 | |||||
3-Year Book Growth Rate | 4.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 15.4 | |||||
9-Day RSI | 28.24 | |||||
14-Day RSI | 35.13 | |||||
3-1 Month Momentum % | -11.87 | |||||
6-1 Month Momentum % | 7.11 | |||||
12-1 Month Momentum % | 12.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 31.84 | |||||
Quick Ratio | 31.5 | |||||
Cash Ratio | 30.92 | |||||
Days Inventory | 23.77 | |||||
Days Sales Outstanding | 33.06 | |||||
Days Payable | 54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -27.6 | |||||
Shareholder Yield % | -18.99 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 16.68 | |||||
Operating Margin % | -16.91 | |||||
Net Margin % | -14.32 | |||||
EBITDA Margin % | -11.4 | |||||
FCF Margin % | -10.53 | |||||
OCF Margin % | -10.42 | |||||
ROE % | -6.25 | |||||
ROA % | -5.7 | |||||
ROIC % | -21.95 | |||||
3-Year ROIIC % | 68.44 | |||||
ROC (Joel Greenblatt) % | -49.84 | |||||
ROCE % | -6.2 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 6.77 | |||||
PB Ratio | 3.25 | |||||
Price-to-Tangible-Book | 3.25 | |||||
EV-to-EBIT | -52 | |||||
EV-to-EBITDA | -65.64 | |||||
EV-to-Revenue | 7.49 | |||||
EV-to-FCF | -74.58 | |||||
Price-to-GF-Value | 2.8 | |||||
Price-to-Projected-FCF | 12.49 | |||||
Price-to-Median-PS-Value | 2.23 | |||||
| Price-to-Net-Current-Asset-Value | 4.25 | |||||
| Price-to-Net-Cash | 4.38 | |||||
Earnings Yield (Greenblatt) % | -1.92 | |||||
FCF Yield % | -1.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sagittarius Life Science Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 346.08 | ||
| EPS (TTM) (NT$) | -1.06 | ||
| Beta | -0.6699 | ||
| 3-Year Sharpe Ratio | 0.16 | ||
| 3-Year Sortino Ratio | 0.39 | ||
| Volatility % | 45.78 | ||
| 14-Day RSI | 35.13 | ||
| 14-Day ATR (NT$) | 1.407225 | ||
| 20-Day SMA (NT$) | 52.215 | ||
| 12-1 Month Momentum % | 12.1 | ||
| 52-Week Range (NT$) | 43.95 - 67 | ||
| Shares Outstanding (Mil) | 67.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sagittarius Life Science Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sagittarius Life Science Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| 1.04866:1 Stock Split | 2016-08-17 | 150.34 (-8.88%) | ||
| 0.3368:1 Stock Split | 2009-11-17 | 29.20 (+6.12%) | ||
| 1:1 Stock Split | 2006-11-17 | -- |
Show
Entries
Sagittarius Life Science Corp Frequently Asked Questions
What is Sagittarius Life Science Corp(ROCO:3205)'s stock price today?
The current price of ROCO:3205 is NT$50.20. The 52 week high of ROCO:3205 is NT$67.00 and 52 week low is NT$43.95.
When is next earnings date of Sagittarius Life Science Corp(ROCO:3205)?
The next earnings date of Sagittarius Life Science Corp(ROCO:3205) is .
Does Sagittarius Life Science Corp(ROCO:3205) pay dividends? If so, how much?
Sagittarius Life Science Corp(ROCO:3205) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Sagittarius Life Science Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers